Revenue Growth183% revenue growth demonstrates meaningful commercial traction for Fermentalg's microalgae ingredients. Sustainable top-line expansion supports scale economics, helps absorb fixed costs, enables reinvestment in capacity and R&D, and strengthens long-term customer relationships if continued.

Improved Operating Cash FlowThe sharp improvement in operating cash flow (deficit down to €0.53M) indicates better cash management and operational execution. If sustained, this reduces near-term funding needs, extends runway for commercialization, and allows reinvestment into production and margin improvement initiatives.

Moderate Leverage / Strong Equity RatioA D/E of 0.38 and a 64% equity ratio provide financial flexibility and a meaningful equity cushion. Moderate leverage lowers solvency risk during scale-up, preserves ability to access debt markets if needed, and supports continued investment in commercializing microalgae products over the medium term.

Bears Say

Large Net Losses And Negative MarginsA €12.88M net loss with EBIT/EBITDA margins around -80%/-87% shows current unit economics are far from sustainable. Without durable margin recovery through cost improvements, pricing, or mix shifts toward higher-margin products, continued losses will require ongoing financing and hinder path to profitability.

Negative Free Cash FlowDespite OCF improvement, FCF remains negative at €-2.0M, meaning the business still consumes cash after investments. Persistent negative FCF forces reliance on external financing, risks dilution or higher-cost borrowing, and limits the company's ability to self-fund capacity expansion or R&D long term.

Rising Total LiabilitiesAn increase in total liabilities reduces financial headroom and can raise refinancing, interest, or covenant risk if growth slows. Higher liabilities limit flexibility for strategic investments, raise fixed obligations, and could necessitate operational tightening or expensive financing to preserve liquidity during scale-up.

1F6 FAQ

What was Fermentalg SA’s price range in the past 12 months?

Fermentalg SA lowest stock price was €0.28 and its highest was €0.63 in the past 12 months.

What is Fermentalg SA’s market cap?

Fermentalg SA’s market cap is €39.06M.

When is Fermentalg SA’s upcoming earnings report date?

Fermentalg SA’s upcoming earnings report date is Apr 02, 2026 which is in 42 days.

How were Fermentalg SA’s earnings last quarter?

Fermentalg SA released its earnings results on Sep 11, 2025. The company reported -€0.043 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.043.

Is Fermentalg SA overvalued?

According to Wall Street analysts Fermentalg SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Fermentalg SA pay dividends?

Fermentalg SA does not currently pay dividends.

What is Fermentalg SA’s EPS estimate?

Fermentalg SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Fermentalg SA have?

Fermentalg SA has 89,844,100 shares outstanding.

What happened to Fermentalg SA’s price movement after its last earnings report?

Fermentalg SA reported an EPS of -€0.043 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.735%.

Which hedge fund is a major shareholder of Fermentalg SA?

Currently, no hedge funds are holding shares in DE:1F6

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Fermentalg SA

Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.